Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-2020 | 08-2019 | 08-2018 | 08-2017 | 08-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,511 | -14,355 | -12,727 | -10,480 | -10,964 |
| Depreciation Amortization | 7 | 8 | 6 | 5 | 4 |
| Other Working Capital | -3,158 | 290 | -3,604 | 2,873 | 15,043 |
| Other Operating Activity | 2,222 | 1,117 | 1,668 | 1,771 | 572 |
| Operating Cash Flow | $-12,440 | $-12,940 | $-14,657 | $-5,831 | $4,655 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,709 | 15,514 | 8,043 | 21,542 | 6,275 |
| PPE Investments | -82 | -15 | -5 | -7 | -9 |
| Purchase Of Investment | N/A | -4,237 | -15,040 | -17,230 | -22,274 |
| Other Investing Activity | -1 | -3 | -2 | -3 | -2 |
| Investing Cash Flow | $4,626 | $11,259 | $-7,004 | $4,302 | $-16,010 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23,786 | N/A | 22,654 | 1,586 | 12,043 |
| Financing Cash Flow | $23,786 | $N/A | $22,654 | $1,586 | $12,043 |
| Exchange Rate Effect | -5 | 14 | 34 | 5 | 6 |
| Beginning Cash Position | 3,329 | 4,996 | 3,969 | 3,907 | 3,213 |
| End Cash Position | 19,296 | 3,329 | 4,996 | 3,969 | 3,907 |
| Net Cash Flow | $15,967 | $-1,667 | $1,027 | $62 | $694 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,440 | -12,940 | -14,657 | -5,831 | 4,655 |
| Capital Expenditure | -82 | -15 | -5 | -7 | -9 |
| Free Cash Flow | -12,522 | -12,955 | -14,662 | -5,838 | 4,646 |